Gary Lichtenstein, MD
Disclosures: Consultant-Abbvie-IBD|Consultant-cellceutrix-IBD|Honorarium for serving as Associate Editor to American Journal of Gastroenterology-American College of Gastroenterology- American Journal of Gastroenterology-IBD|Research and Consultant-Celgene-IBD|Consultant-Endo Pharmaceuticals-IBD|Consultant-Ferring-IBD|Journal Executive Editor-Gastroenterology and Hepatology-Gastroenterology|Consultant-Gilead-IBD|Consultant, Funding for IBD fellowship, Research-Janssen OrthoBiotech-IBD|Consultant-Luitpold / American Regent-IBD|Consultant-Merck-IBD|Consulting-Morphic Therapeutics-IBD|Consultant, Funding for Penn IBD Fellowship, Research-Pfizer, Inc.-IBD|Consultant-Prometheus-IBD|Consultant-Romark-IBD|Consultant, Research-Salix, valeant-IBD|Consultant-Shire Pharmaceuticles-IBD|Book Royalty-SLACK, Inc|Editor Honorarium-Springer Science and Business media-IBD|IBD fellowship support, research, consultant-Takeda|Consultant, research-UCB, Inc-IBD|author Honorarium-Up-To- Date-IBD|Consultant-Eli Lilly and Company-IBD|Royalty for writing a textbook-Professional Communications, Inc-IBD
No Bio Available.